Analysts Set Humana Inc. (NYSE:HUM) PT at $285.68

Humana Inc. (NYSE:HUM - Get Free Report) has been assigned an average rating of "Hold" from the twenty-two brokerages that are currently covering the firm, Marketbeat reports. Seventeen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $285.68.

A number of brokerages have recently commented on HUM. Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. JPMorgan Chase & Co. decreased their target price on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. StockNews.com downgraded Humana from a "buy" rating to a "hold" rating in a research report on Tuesday, March 18th. Barclays lifted their price objective on Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a report on Thursday, February 13th. Finally, Piper Sandler raised their target price on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th.

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.37% of the company's stock.

Remove Ads

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in HUM. Pinnacle Wealth Management Advisory Group LLC increased its position in shares of Humana by 3.6% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock valued at $272,000 after acquiring an additional 37 shares during the period. Atlas Brown Inc. grew its stake in Humana by 0.6% during the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock valued at $1,611,000 after purchasing an additional 38 shares during the last quarter. Moors & Cabot Inc. increased its holdings in shares of Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider's stock valued at $519,000 after purchasing an additional 40 shares during the period. Mather Group LLC. raised its stake in shares of Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock worth $60,000 after purchasing an additional 41 shares during the last quarter. Finally, Capital Advisors Ltd. LLC raised its stake in shares of Humana by 26.1% in the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after purchasing an additional 43 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Trading Up 0.7 %

HUM traded up $1.79 during trading hours on Friday, reaching $273.51. 1,392,561 shares of the company's stock traded hands, compared to its average volume of 1,714,179. The firm has a 50-day moving average price of $271.01 and a 200 day moving average price of $275.60. The firm has a market capitalization of $33.01 billion, a PE ratio of 27.49, a PEG ratio of 2.05 and a beta of 0.57. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana has a 52-week low of $213.31 and a 52-week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, sell-side analysts predict that Humana will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.29%. The ex-dividend date of this dividend is Friday, March 28th. Humana's dividend payout ratio is presently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.